European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations (PCWP) and Healthcare Professionals Working Party (HCPWP) joint meeting

• Date:
  Tuesday, 3 June 2014, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. Participants will be updated on a number of EMA initiatives including RMP summaries, conflicts of interest policy and access to clinical trial data policy. The European Commission will provide updates on the new clinical trial regulation and a study on off-label use. Feedback from four NCAs involving patients and healthcare professionals in regulatory decisions will be discussed in the afternoon session. Registration by invitation only.

Documents

Agenda - European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting - 3 June 2014

Reference Number: EMA/136044/2014

List of participants of the European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting - 3 ...

Reference Number: EMA/291057/2014

Minutes of the European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting - 3 June 2014

AdoptedReference Number: EMA/335623/2014

Presentation - Update on the new clinical trial regulation (Fabio D'Atri)

Presentation - Clinical trials regulation: European Medicines Agency's role (Anabela Marcal)

Presentation - Summaries of risk management plan (Juan Garcia Burgos)

Presentation - Reinforcing the collaboration with healthcare professionals and patient associations - ANSM (Dany Bonnet)

Presentation - Involving patients and healthcare professionals in regulatory decisions - MEB (Sandra Kruger-Peters)

Presentation - Involving patients and healthcare professionals - MHRA(Janine Jolly)

Presentation - Patients and healthcare professionals involvement in regulatory decisions - MPA (Jane Ahlqvist Rastad)